|
|
||||||||
The Journal of Immunology, Vol 156, Issue 1 100-107, Copyright © 1996 by American Association of Immunologists
ARTICLES |
O Silvennoinen, H Nishigaki, A Kitanaka, M Kumagai, C Ito, F Malavasi, Q Lin, ME Conley and D Campana
Department of Virology, University of Helsinki, Finland.
Ligation of CD38 inhibits proliferation and induces apoptosis of human immature B cells, but the molecular mechanisms underlying this function are unknown. We found that CD38 dimerization with the specific mAbs T16 and IB4 induces rapid and transient tyrosine phosphorylation of several intracellular proteins in the immature B cell lines RS4;11, REH, 380, Nalm6, and OP-1. This effect could be markedly reduced by incubating cells with the tyrosine kinase inhibitors genistein, staurosporine, and herbimycin A. CD38 dimerization induced tyrosine phosphorylation of the protein kinase syk and increased syk kinase activity. CD38 dimerization also induced tyrosine phosphorylation of phospholipase C-gamma and of the p85 subunit of phosphatidylinositol 3-kinase (PI 3-K). The latter was accompanied by a distinct increase in PI 3-kinase activity in the immunoprecipitates obtained with an anti-phosphotyrosine Ab. In contrast to the signaling triggered by surface Ig engagement in B lymphocytes, CD38 ligation did not appear to induce tyrosine phosphorylation of the src-like protein tyrosine kinases lyn, fyn, and btk, or of vav- and ras-GTPase-activating protein, nor did it induce detectable changes in cytosolic CA2+ concentrations. CD38 signaling also differed from cytokine-induced signaling in that it did not cause tyrosine phosphorylation of Jak1 and Jak2. Finally, CD38 ligation did not inhibit IL-3-induced tyrosine phosphorylation of Jak2. These results identify CD38 as a cell surface receptor with signal transduction properties activated by dimerization. Induction of signal transduction by CD38 ligation implies the existence of a yet unidentified natural ligand of CD38.
This article has been cited by other articles:
![]() |
F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A. L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology Physiol Rev, July 1, 2008; 88(3): 841 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mayo, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, M.-J. Moutin, F. E. Lund, and R. Stein Dual Role of CD38 in Microglial Activation and Activation-Induced Cell Death J. Immunol., July 1, 2008; 181(1): 92 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, T. Vaisitti, S. Aydin, E. Ferrero, and F. Malavasi In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia Blood, August 15, 2006; 108(4): 1135 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Lund, H. Muller-Steffner, H. Romero-Ramirez, M. E. Moreno-Garcia, S. Partida-Sanchez, M. Makris, N. J. Oppenheimer, L. Santos-Argumedo, and F. Schuber CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism Int. Immunol., July 1, 2006; 18(7): 1029 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Zilber, N. Setterblad, T. Vasselon, C. Doliger, D. Charron, N. Mooney, and C. Gelin MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes Blood, November 1, 2005; 106(9): 3074 - 3081. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kaku, K. Horikawa, Y. Obata, I. Kato, H. Okamoto, N. Sakaguchi, S. Gerondakis, and K. Takatsu NF-{kappa}B is required for CD38-mediated induction of C{gamma}1 germline transcripts in murine B lymphocytes Int. Immunol., September 1, 2002; 14(9): 1055 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mallone, A. Funaro, M. Zubiaur, G. Baj, C. M. Ausiello, C. Tacchetti, J. Sancho, C. Grossi, and F. Malavasi Signaling through CD38 induces NK cell activation Int. Immunol., April 1, 2001; 13(4): 397 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mallone, E. Ortolan, G. Baj, A. Funaro, S. Giunti, E. Lillaz, F. Saccucci, M. Cassader, P. Cavallo-Perin, and F. Malavasi Autoantibody Response to CD38 in Caucasian Patients With Type 1 and Type 2 Diabetes: Immunological and Genetic Characterization Diabetes, April 1, 2001; 50(4): 752 - 762. [Abstract] [Full Text] |
||||
![]() |
C. F. Webb, Y. Yamashita, N. Ayers, S. Evetts, Y. Paulin, M. E. Conley, and E. A. Smith The Transcription Factor Bright Associates with Bruton's Tyrosine Kinase, the Defective Protein in Immunodeficiency Disease J. Immunol., December 15, 2000; 165(12): 6956 - 6965. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Rebecchi and S. N. Pentyala Structure, Function, and Control of Phosphoinositide-Specific Phospholipase C Physiol Rev, October 1, 2000; 80(4): 1291 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Cho, M.-K. Han, Y. B. Choi, Y. Yun, J. Shin, and U.-H. Kim Direct Interaction of the CD38 Cytoplasmic Tail and the Lck SH2 Domain. CD38 TRANSDUCES T CELL ACTIVATION SIGNALS THROUGH ASSOCIATED Lck J. Biol. Chem., January 21, 2000; 275(3): 1685 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Todisco, T. Suzuki, K. Srivannaboon, E. Coustan-Smith, S. C. Raimondi, F. G. Behm, A. Kitanaka, and D. Campana CD38 ligation inhibits normal and leukemic myelopoiesis Blood, January 15, 2000; 95(2): 535 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sconocchia, J. A. Titus, A. Mazzoni, A. Visintin, F. Pericle, S. W. Hicks, F. Malavasi, and D. M. Segal CD38 Triggers Cytotoxic Responses in Activated Human Natural Killer Cells Blood, December 1, 1999; 94(11): 3864 - 3871. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Borrione, S. Peola, S. Mariani, B. Besostri, R. Mallone, F. Malavasi, A. Pileri, and M. Massaia CD38 Stimulation Lowers the Activation Threshold and Enhances the Alloreactivity of Cord Blood T Cells by Activating the Phosphatidylinositol 3-Kinase Pathway and Inducing CD73 Expression J. Immunol., May 15, 1999; 162(10): 6238 - 6246. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kitanaka, T. Suzuki, C. Ito, H. Nishigaki, E. Coustan-Smith, T. Tanaka, Y. Kubota, and D. Campana CD38-Mediated Signaling Events in Murine Pro-B Cells Expressing Human CD38 With or Without Its Cytoplasmic Domain J. Immunol., February 15, 1999; 162(4): 1952 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Konopleva, Z. Estrov, S. Zhao, M. Andreeff, and K. Mehta Ligation of Cell Surface CD38 Protein with Agonistic Monoclonal Antibody Induces a Cell Growth Signal in Myeloid Leukemia Cells J. Immunol., November 1, 1998; 161(9): 4702 - 4708. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Laser, V. S. Kasi, M. Hamawaki, G. Cooper IV, C. M. Kerr, and D. Kuppuswamy Differential Activation of p70 and p85 S6 Kinase Isoforms during Cardiac Hypertrophy in the Adult Mammal J. Biol. Chem., September 18, 1998; 273(38): 24610 - 24619. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Cockayne, T. Muchamuel, J. C. Grimaldi, H. Muller-Steffner, T. D. Randall, F. E. Lund, R. Murray, F. Schuber, and M. C. Howard Mice Deficient for the Ecto-Nicotinamide Adenine Dinucleotide Glycohydrolase CD38 Exhibit Altered Humoral Immune Responses Blood, August 15, 1998; 92(4): 1324 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morra, M. Zubiaur, C. Terhorst, J. Sancho, and F. Malavasi CD38 is functionally dependent on the TCR/CD3 complex in human T cells FASEB J, May 1, 1998; 12(7): 581 - 592. [Abstract] [Full Text] |
||||
![]() |
E. Zocchi, A. Daga, C. Usai, L. Franco, L. Guida, S. Bruzzone, A. Costa, C. Marchetti, and A. De Flora Expression of CD38 Increases Intracellular Calcium Concentration and Reduces Doubling Time in HeLa and 3T3 Cells J. Biol. Chem., April 3, 1998; 273(14): 8017 - 8024. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Venkataraman, N. Muthusamy, S. Muthukkumar, and S. Bondada Activation of Lyn, Blk, and Btk But Not Syk in CD72-Stimulated B Lymphocytes J. Immunol., April 1, 1998; 160(7): 3322 - 3329. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Funaro, M. Reinis, O. Trubiani, S. Santi, R. Di Primio, and F. Malavasi CD38 Functions Are Regulated Through an Internalization Step J. Immunol., March 1, 1998; 160(5): 2238 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kitanaka, H. Mano, M. Ellen Conley, and D. Campana Expression and Activation of the Nonreceptor Tyrosine Kinase Tec in Human B Cells Blood, February 1, 1998; 91(3): 940 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, M. Morra, R. Mallone, C. M. Ausiello, E. Prager, G. Garbarino, U. Dianzani, H. Stockinger, and F. Malavasi Human CD38 (ADP-Ribosyl Cyclase) Is a Counter-Receptor of CD31, an Ig Superfamily Member J. Immunol., January 1, 1998; 160(1): 395 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zubiaur, O. Fernandez, E. Ferrero, J. Salmeron, B. Malissen, F. Malavasi, and J. Sancho CD38 Is Associated with Lipid Rafts and upon Receptor Stimulation Leads to Akt/Protein Kinase B and Erk Activation in the Absence of the CD3-zeta Immune Receptor Tyrosine-based Activation Motifs J. Biol. Chem., January 4, 2002; 277(1): 13 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Zilber, S. Gregory, R. Mallone, S. Deaglio, F. Malavasi, D. Charron, and C. Gelin CD38 expressed on human monocytes: A coaccessory molecule in the superantigen-induced proliferation PNAS, March 14, 2000; 97(6): 2840 - 2845. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |